Extclav-DS Dry Syrup is a potent antibiotic formulation combining Amoxycillin (400mg/5ml) and Clavulanic Acid (57mg/5ml), designed to combat a wide range of bacterial infections. Amoxycillin, a broad-spectrum penicillin antibiotic, works by inhibiting the synthesis of bacterial cell walls, leading to the destruction of susceptible bacteria. Clavulanic Acid, a beta-lactamase inhibitor, enhances the efficacy of Amoxycillin by preventing the breakdown of the antibiotic by beta-lactamase enzymes produced by resistant bacteria. This combination makes Extclav-DS effective against infections caused by beta-lactamase-producing strains, which are often resistant to Amoxycillin alone. It is commonly prescribed for respiratory tract infections, urinary tract infections, skin and soft tissue infections, and otitis media. The dry syrup formulation is particularly suitable for pediatric patients who have difficulty swallowing tablets, ensuring accurate dosing and improved compliance. Extclav-DS should be used under medical supervision, with adherence to the prescribed dosage and duration to prevent antibiotic resistance. Patients with a history of penicillin allergy should avoid this medication. Common side effects may include gastrointestinal disturbances such as diarrhea, nausea, and vomiting. Overall, Extclav-DS Dry Syrup offers an effective and convenient treatment option for bacterial infections requiring combination antibiotic therapy.